Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Investigating the Efficacy of Autologous, Adipose-derived Mesenchymal Stem Cell Therapy in Women Aged 40-50
Authors not listed
Vinmec Research Institute of Stem Cell and Gene Technology · 2023
Abstract
Female Sexual Dysfunction (FSD) represents a critical public health challenge, significantly impacting women's physical, psychological, and social well-being. Despite its prevalence, cultural barriers in Vietnam and other Asian countries often limit awareness and research on FSD. Existing treatments, such as hormone therapy, carry risks like cardiovascular complications and cancer, emphasizing the need for innovative interventions. This study investigates FSD-related factors and evaluates the efficacy of autologous adipose-derived mesenchymal stem cell (MSC) therapy as a novel approach.
In this phase 2 clinical trial, MSCs are intravenously administered at a dose of 10\^6 cells/kg. These autologous cells, which are non-immunogenic, survive for approximately 8 weeks and release growth factors and cytokines to enhance vascular supply, reduce harmful inflammation, and counteract cellular aging. The study enrolls 50 female participants randomized into two groups: Group A receives MSC infusions at months 0 and 3, while Group B acts as a control for 6 months.
Outcomes are assessed through clinical evaluations, blood tests for hormonal levels, molecular analyses, and internationally validated quality-of-life and sexual function scales. Evaluations are conducted at baseline, 3, and 6 months post-infusion. This research seeks to provide robust evidence for the safety and efficacy of MSC therapy, offering a promising alternative to conventional treatments while addressing a critical gap in women's health.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-01 MST
Cite this
APA
Anonymous. (2023). Investigating the Efficacy of Autologous, Adipose-derived Mesenchymal Stem Cell Therapy in Women Aged 40-50. <em>Vinmec Research Institute of Stem Cell and Gene Technology</em>. https://clinicaltrials.gov/study/NCT06726538
Vancouver
Anonymous. Investigating the Efficacy of Autologous, Adipose-derived Mesenchymal Stem Cell Therapy in Women Aged 40-50. Vinmec Research Institute of Stem Cell and Gene Technology. 2023.
BibTeX
@misc{anon2023Invest,
title = {Investigating the Efficacy of Autologous, Adipose-derived Mesenchymal Stem Cell Therapy in Women Aged 40-50},
author = {Anonymous},
journal = {Vinmec Research Institute of Stem Cell and Gene Technology},
year = {2023},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Stem Cells International 2019
Open access · CC-BY
Interaction between Mesenchymal Stem Cells and Intervertebral Disc Microenvironment: From Cell Therapy to Tissue Engineering
Journal of the National Cancer Center 2026
Open access · OA
Intrinsic and extrinsic regulators of cancer dormancy and awakening.
Frontiers in Immunology 2013
Open access · CC-BY
Mesenchymal Stem Cells in Tissue Repair
First Affiliated Hospital of Wannan Medical College 2025
Open access · US-GOV
Impact of Ultrasound-Guided Microbubble Clearance During CRRT Circuit Priming on Filter Lifespan: A Randomized Crossover Pilot Trial
Research Centre for Natural Sciences 2024
Open access · US-GOV
The Effects of a Hungarian Multidomain Lifestyle Intervention on Brain Health in Older Adults
Pediatric Research 2008
Citation only